(Q40365013)

19 September 2017

Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients (English)

1 reference

19 September 2017

1 reference

Thomsett MJ

1

1 reference

19 September 2017

Conte FA

series ordinal

2

1 reference

19 September 2017

Kaplan SL

series ordinal

3

1 reference

19 September 2017

Grumbach MM

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 November 1980

1 reference

The Journal of Pediatrics

19 September 2017

1 reference

19 September 2017

97

1 reference

19 September 2017

5

1 reference

19 September 2017

728-735

1 reference

AN EVALUATION OF SEVENTY-FIVE PATIENTS WITH HYPOPITUITARISM BEGINNING IN CHILDHOOD.

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Iatrogenic hypopituitarism in craniopharyngioma: Unexplained catch-up growth in three children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Normal growth with subnormal growth-hormone levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Craniopharyngioma in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Eye signs in craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Hypothalamic-pituitary function in patients with craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Craniopharyngioma: The Role of Insulin in Promoting Postoperative Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Clinical determination of protein-bound iodine in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

A radioimmunoassay for measurement of thyroxine in unextracted serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Growth and growth hormone. II. A comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Hormonal Changes in Puberty I. Correlation of Serum Luteinizing Hormone and Follicle Stimulating Hormone with Stages of Puberty, Testicular Size, and Bone Age in Normal Boys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Craniopharyngioma: based on 160 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Case report of an adamantinoma present at birth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Craniopharyngiomas treated by a combination of surgery and radiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Management of craniopharyngioma in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Craniopharyngiomas in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Normal CAT scans in craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Prolactin and somatomedin in hypopituitary patients with "catch up" growth following operations for craniopharyngioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Letter: Growth with absent growth hormone by radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Late results of radical excision of craniopharyngiomas in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Craniopharyngiomas--a summary of 85 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Radiotherapy in the management of craniopharyngiomas: further experiences and late results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Combined modality therapy for intracranial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Craniopharyngiomas: a clinical and pathological review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Radiation therapy of craniopharyngioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Visual complications following irradiation for pituitary adenomas and craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Hypothalamic hypopituitarism following external radiotherapy for tumours distant from the adenohypophysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Delayed onset of hypopituitarism: sequelae of therapeutic irradiation of central nervous system, eye, and middle ear tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Malignant astrocytoma following radiotherapy of a craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Residual disabilities in children treated for intracranial space-occupying lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

Endocrine function in patients with suprasellar and hypothalamic tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980254-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(80)80254-X

1 reference

19 September 2017

1 reference